Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Integrator complex subunit 4-like pseudogene (ENSG00000261719) is a non-coding sequence in the human genome related by sequence similarity to the gene encoding Integrator complex subunit 4 (INTS4)[4]. Pseudogenes are typically classified as genomic DNA sequences similar to normal genes but are generally non-functional due to disabling mutations or lack of key regulatory elements[3][5]. While most pseudogenes do not code for functional proteins, some may be transcribed to RNA and play regulatory roles, such as acting as competing endogenous RNAs or regulators of parental gene expression[1][3][5]. However, there is no evidence that ENSG00000261719 encodes a functional product or is involved in any particular disease or pathway. Canonical gene counterpart (active protein-coding gene): Integrator complex subunit 4 (INTS4), which is a scaffolding component of the Integrator complex involved in RNA polymerase II-mediated processing of small nuclear RNAs[6]. Pseudogene classification: It is classified as a pseudogene ("Integrator complex subunit 4-like") meaning it is related in sequence to the INTS4 protein-coding gene, but is generally considered non-functional for protein production[3][4][5]. Functional studies: The vast majority of pseudogenes do not produce a functional protein and are not considered direct drug or therapeutic targets[3][5]. There is some ongoing research into potential biological functions of certain transcribed pseudogenes, but no evidence currently exists for ENSG00000261719[1][5]. If more specific information about function, disease link, or druggability is required for this sequence, it will almost certainly be null, as it is not a recognized functional gene or therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Integrator complex subunit 4-like pseudogene.